Sacubitril/valsartan attenuates atrial structural remodelling in atrial fibrillation patients

AIMS: Radiofrequency catheter ablation (RFCA) is now an established therapeutic option for patients with atrial fibrillation (AF), but the long‐term recurrence rate of AF is still high. Sacubitril/valsartan (Sac/Val) is superior to valsartan in attenuating ventricular remodelling and improving clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Liu, Zhang, Min, Hao, Zhiheng, Wang, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288756/
https://www.ncbi.nlm.nih.gov/pubmed/35437929
http://dx.doi.org/10.1002/ehf2.13937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288756/
https://www.ncbi.nlm.nih.gov/pubmed/35437929
http://dx.doi.org/10.1002/ehf2.13937

Ejemplares similares